By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Clearmind Medicine Inc.

Clearmind Medicine Inc. (CMND)

NASDAQ Market Data in USD, Fundamentals in CAD
$1.05
+$0.03
+2.56%
Last Update: 11 Sept 2025, 20:00
$5.65M
Market Cap
-1.22
P/E Ratio (TTM)
Forward Dividend Yield
$0.80 - $2.18
52 Week Range

CMND Stock Price Chart

Explore Clearmind Medicine Inc. interactive price chart. Choose custom timeframes to analyze CMND price movements and trends.

CMND Company Profile

Discover essential business fundamentals and corporate details for Clearmind Medicine Inc. (CMND) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

15 Nov 2022

Employees

4.00

CEO

Adi Zuloff-Shani

Description

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

CMND Financial Timeline

Browse a chronological timeline of Clearmind Medicine Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 15 Sept 2025

Earnings released on 12 Jun 2025

EPS came in at -$0.16 .

Earnings released on 13 Mar 2025

EPS came in at -$0.24 .

Earnings released on 22 Jan 2025

EPS came in at -$0.11 .

Earnings released on 16 Sept 2024

EPS came in at -$0.59 .

Earnings released on 13 Jun 2024

EPS came in at -$0.28 .

Earnings released on 18 Mar 2024

EPS came in at -$0.90 .

Earnings released on 29 Jan 2024

EPS came in at -$0.60 .

Stock split effective on 28 Nov 2023

Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 13 Sept 2023

EPS came in at -$0.08 .

Earnings released on 14 Jun 2023

EPS came in at -$0.90 .

Earnings released on 17 Mar 2023

EPS came in at -$1.80 .

Earnings released on 3 Feb 2023

EPS came in at -$4.37 .

Stock split effective on 11 Oct 2022

Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 3 Oct 2022

Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 30 Sept 2022

Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 Jul 2022

EPS came in at -$3.88 .

Earnings released on 30 Apr 2022

EPS came in at -$6.18 .

Earnings released on 31 Jan 2022

EPS came in at -$3.95 .

Earnings released on 31 Oct 2021

EPS came in at -$4.80 .

Earnings released on 31 Jul 2021

EPS came in at -$2.43 .

Earnings released on 30 Apr 2021

EPS came in at -$0.72 .

Earnings released on 31 Jan 2021

EPS came in at -$0.36 .

Earnings released on 31 Oct 2020

EPS came in at -$0.20 .

CMND Stock Performance

Access detailed CMND performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run